Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

45 results about "Methylmagnesium chloride" patented technology

Methylmagnesium chloride is an organometallic compound with the general formula CH₃MgCl. This highly flammable, colorless, and moisture sensitive material is the simplest Grignard reagent and is commercially available, usually as a solution in tetrahydrofuran.

Preparation method of 2-dimethyl-2-octanol

The invention discloses a preparation method of 2-dimethyl-2-octanol. Methyl Grignard reagent is prepared by using methyl magnesium chloride or methyl magnesium bromide as an initiator. The 2-dimethyl-2-octanol is prepared by carrying out reaction of the methyl Grignard reagent and 2-octanone. The preparation method of the 2-dimethyl-2-octanol is suitable for continuous production, iodine is used for initiation for the first time, halogenated methane liquid state is added in the iodine in a dropwise manner to prepare an methyl magnesium chloride initiator and an methyl magnesium bromide initiator, and the methyl Grignard reagent produced in the previous production is completely adopted as the initiator in subsequent production to carry out the continuous production. The properties of the initiators of the preparation method are relatively stable. The initiator is easy to store, compared with a common initiator, the initiator has the advantages of being fast in initiation speed, strong in generality, low in usage, convenient to store and low in toxicity and the like, and is especially suitable for the preparation for the Grignard reagent in mass production. According to the preparation method of the 2-dimethyl-2-octanol, preparation safety is good, and production yield is high.
Owner:HUAIAN WAN BANG SPICE IND CO LTD

Preparation method of 4-(1-hydroxy-1-methylethyl)-2-propylimidazolium iodide-5-carboxylate

The invention relates to a preparation method of 4-(1-hydroxy-1-methylethyl)-2-propylimidazolium iodide-5-carboxylate, which belongs to the technical field of pharmaceutical intermediate synthesis. For solving the problems that the content of products is low, and a large amount of organic solvents are required to be adopted for recrystallization, a preparation method of 4-(1-hydroxy-1-methylethyl)-2-propylimidazolium iodide-5-carboxylate is provided. The method comprises the following steps: reacting 2-propylimidazolium iodide-4,5-dicarboxylate with methylmagnesium chloride so as to obtain an oily matter; adding an inorganic acid and activated carbon into the oily matter, and heating the obtained mixture so as to carry out a salt forming reaction, so that the obtained mixture is transferred into a corresponding acidic salt; filtering the acidic salt so as to obtain filter liquor of the corresponding acidic salt; and controlling the temperature of the filter liquor, adding an alkaline reagent into the filter liquor so as to adjust the pH value of the obtained mixture to 7, and then carrying out cooling crystallization on the obtained mixture so as to obtain 4-(1-hydroxy-1-methylethyl)-2-propylimidazolium iodide-5-carboxylate. The method disclosed by the invention is simple and short in process, an organic solvent is not required to be adopted for recrystallization, and the purity and yield of obtained products are high.
Owner:ZHEJIANG LEPU PHARMA CO LTD

Synthetic method for preparing olmesartan medoxomil intermediate through continuous flow

The invention discloses a synthetic method for preparing an olmesartan medoxomil intermediate through continuous flow, which belongs to the technical field of drug synthesis. The method comprises the following steps: step (1), dissolving a compound 2-propyl-4,5-imidazole dicarboxylic acid ethyl ester I in an organic solvent to form a reaction phase A; step (2), taking a commercially purchased methyl magnesium chloride solution as a reaction phase B; step (3), pumping the reaction phase A and the reaction phase B into a mixer by using a plunger pump at a certain flow rate, then feeding the mixture into a reactor, retaining for a certain time, quenching by using an acid water phase C, feeding the mixture into an oil-water continuous liquid separator, separating liquid to obtain an organic solution of a compound as shown in a formula II, desolventizing, and recrystallizing to obtain the compound as shown in the formula II. The technical problems of low purity and high cost in the existing preparation process are solved, the product is high in purity and few in impurities, the content of the key impurity A, the key impurity B and the key impurity C can be controlled to be 0.1% or below, the raw materials are cheap and easy to obtain, the reaction condition is mild, operation is easy and convenient, the synthesis efficiency is high, and the method is suitable for industrial production. A novel continuous flow path is provided for preparing the olmesartan medoxomil and the intermediate.
Owner:拓信达(启东)医药生物科技有限公司 +2

A kind of synthetic method of continuous flow preparation olmesartan medoxomil intermediate

The invention discloses a continuous flow method for preparing an intermediate of olmesartan medoxomil, which belongs to the technical field of pharmaceutical synthesis and comprises the following steps: step (1), compounding formula I compound 2-propyl-4,5-imidazole dicarboxylic acid Ethyl ester I is dissolved in organic solvent to form reaction phase A, step (2), the methylmagnesium chloride solution of commercialization purchase is used as reaction phase B, step (3), reaction phase A and reaction phase B are used plunger pump to Pump it into the mixer at a certain flow rate, then enter the reactor, keep it for a certain period of time, quench it with the acidic water phase C, and enter the oil-water continuous separator for liquid separation, that is, the organic solution of the compound formula II is obtained. The compound of formula II can be obtained by recrystallization, which solves the technical problems of low purity and high cost in the existing production process. The product of the present invention has high purity and few impurities, and the content of key impurity A, key impurity B and key impurity C can be controlled at 0.1 % or less, and the raw materials are cheap and easy to obtain, the reaction conditions are mild, the operation is simple, the synthesis efficiency is high, and it is suitable for industrial production. It provides a new continuous flow route for the preparation of olmesartan medoxomil and intermediates.
Owner:拓信达(启东)医药生物科技有限公司 +2
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products